Olux-E FDA Approval History
FDA Approved: Yes (First approved January 12, 2007)
Brand name: Olux-E
Generic name: clobetasol propionate
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Psoriasis, Eczema
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
Development timeline for Olux-E
| Date | Article |
|---|---|
| Jan 12, 2007 | Approval Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
